Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 40,000 shares at $25.60 ($1.0M) on 2012-12-05, disclosed to the SEC on 2012-12-06.
Open-market sale of $1.0M SGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.45 | 10,000 | $255K | 24.9% |
| 2 | $25.55 | 10,000 | $256K | 25.0% |
| 3 | $25.75 | 10,000 | $258K | 25.2% |
| 4 | $25.60 | 10,000 | $256K | 25.0% |
| Total | $25.59 avg | 40,000 | $1.0M | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-03 | $1.0M | — | Filing → |